darexaban glucuronide

 

Topic mentions per year

Topic mentions per year

2011-2013
024620112013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
We investigated the effects of ketoconazole on the pharmacokinetics (PK) of the direct clotting factor Xa inhibitor darexaban… (More)
Is this relevant?
2013
2013
1. The absorption, metabolism and excretion of darexaban (YM150), a novel oral direct factor Xa inhibitor, were investigated… (More)
Is this relevant?
2013
2013
AIMS We investigated the effects of rifampicin on the pharmacokinetics (PK) of the direct clotting factor Xa inhibitor darexaban… (More)
Is this relevant?
2013
2013
The clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban after single and multiple once-daily doses… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
2013
2013
The oral direct factor Xa inhibitor darexaban administered intraduodenally prevented venous thrombus formation in both rats and… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2013
2013
BACKGROUND Darexaban (YM150) is a potent direct factor Xa (FXa) inhibitor developed for the prophylaxis of venous and arterial… (More)
  • table 1
  • table 2
  • table 2
  • figure 1
  • table 4
Is this relevant?
2013
2013
BACKGROUND Darexaban is a potent direct factor Xa (FXa) inhibitor developed for prophylaxis of venous and arterial thromboembolic… (More)
Is this relevant?
2012
2012
Darexaban maleate is a novel oral direct factor Xa inhibitor. Darexaban glucuronide (YM-222714) was the major component in plasma… (More)
Is this relevant?
2012
2012
Most synthetic factor Xa (FXa) and thrombin inhibitors examined in pharmacokinetic studies and phase II/III clinical trials have… (More)
  • figure 1
Is this relevant?
2011
2011
Darexaban (YM150) is an oral factor Xa inhibitor developed for the prophylaxis of venous and arterial thromboembolic disease… (More)
Is this relevant?